CD70 anticorps (N-Term)
Aperçu rapide pour CD70 anticorps (N-Term) (ABIN926714)
Antigène
Voir toutes CD70 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- CD70 antibody was raised in rabbit using the N terminal of CD70 as the immunogen
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator.
-
Commentaires
-
CD70 Blocking Peptide, (ABIN936417), is also available for use as a blocking control in assays to test for specificity of this CD70 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CD70 (CD70 Molecule (CD70))
-
Autre désignation
- CD70
-
Sujet
- The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for TNFRSF27/CD27. It is a surface antigen on activated, but not on resting, T and B lymphocytes. It induces proliferation of costimulated T cells, enhances the generation of cytolytic T cells, and contributes to T cell activation. This cytokine is also reported to play a role in regulating B-cell activation, cytotoxic function of natural killer cells, and immunoglobulin sythesis. Synonyms: Polyclonal CD70 antibody, Anti-CD70 antibody, CD70 molecule antibody, CD27L antibody, CD27LG antibody, TNFSF7 antibody.
-
Pathways
- Cancer Immune Checkpoints
Antigène
-